Citation data

CrossRef

Works that cite this article, indexed by Crossref.

63 resultsUpdated November 01, 2026
1

Development and validation of a non-invasive model for diagnosing HBV-related liver cirrhosis

Clinica Chimica Acta 523 (2021)

Xiangyu Zhang; Peiran Huang; Xinyu Wang; Kaiqian Zhou; Feiyu Chen; Cheng Zhou; Lei Yu; Qing Lu; Jian Zhou; Jie Hu; Zheng Wang

2

An unsupervised transfer learning model based on convolutional auto encoder for non-alcoholic steatohepatitis activity scoring and fibrosis staging of liver histopathological images

Neural Computing and Applications 35(14) (2023)

Meryem Altin Karagoz; Bahriye Akay; Alper Basturk; Dervis Karaboga; O. Ufuk Nalbantoglu

3

Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease

Abdominal Radiology 44(3) (2019)

Juan S. Calle-Toro; Suraj D. Serai; Erum A. Hartung; David J. Goldberg; Bradley D. Bolster; Kassa Darge; Sudha A. Anupindi

4

Combined methods of optical spectroscopy and artificial intelligence in the assessment of experimentally induced non-alcoholic fatty liver

Computer Methods and Programs in Biomedicine 198 (2021)

Eduardo J. Arista Romeu; Josué D. Rivera Fernández; Karen Roa Tort; Alma Valor; Galileo Escobedo; Diego A. Fabila Bustos; Suren Stolik; José Manuel de la Rosa; Carolina Guzmán

5

Identification of tissue sections from decellularized liver scaffolds for repopulation experiments

Heliyon 7(2) (2021)

Philipp Felgendreff; Claudia Schindler; Franziska Mussbach; Chichi Xie; Felix Gremse; Utz Settmacher; Uta Dahmen

6

Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction–associated steatohepatitis

Hepatology Communications 8(6) (2024)

Zobair M. Younossi; Kamal Kant Mangla; Tina Landsvig Berentzen; Katrine Grau; Mette Skalshøi Kjær; Steen Ladelund; Louise Maymann Nitze; Crystal Coolbaugh; Chih-Yuan Hsu; Hannes Hagström

7

Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”

Hepatitis Monthly 14(4) (2014)

Sara Manti; Claudio Romano; Valeria Chirico; Martina Filippelli; Caterina Cuppari; Italia Loddo; Carmelo Salpietro; Teresa Arrigo

8

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

Frontiers in Endocrinology 11 (2021)

Andrea Dennis; Matt D. Kelly; Carolina Fernandes; Sofia Mouchti; Jonathan A. Fallowfield; Gideon Hirschfield; Michael Pavlides; Stephen Harrison; Manu V. Chakravarthy; Rajarshi Banerjee; Arun Sanyal

10

Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial

Hepatitis Monthly 17(12) (2017)

Seyed Mohammad Tabatabaee; Seyed Moayed Alavian; Leila Ghalichi; Seyed Mohammad Miryounesi; Kazem Mousavizadeh; Shima Jazayeri; Mohammad Reza Vafa

13

Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Computational and Structural Biotechnology Journal 21 (2023)

Yoshihisa Takahashi; Erdenetsogt Dungubat; Hiroyuki Kusano; Toshio Fukusato

14

Deep learning for automated boundary detection and segmentation in organ donation photography

Innovative Surgical Sciences 10(3) (2025)

Georgios Kourounis; Ali Ahmed Elmahmudi; Brian Thomson; Robin Nandi; Samuel J. Tingle; Emily K. Glover; Emily Thompson; Balaji Mahendran; Chloe Connelly; Beth Gibson; Lucy Bates; Neil S. Sheerin; James Hunter; Hassan Ugail; Colin Wilson

15

This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol

Seminars in Liver Disease 44(02) (2024)

Anja M. Fischer; Nazim Lechea; Harvey O. Coxson

16

Extracellular vesicle-derived candidate biomarker in metabolic dysfunction-associated steatotic liver disease: systematic review and exploratory meta-analysis

Scientific Reports 16(1) (2026)

Swasthika Gurjar; Saraswathi N Bhat; Ramanarayana Bhat A; Athish Shetty; Raghavendra Upadhya; Asha Kamath; Shwetha Kamath; Varashree B S; Madhukar Mallya H; Ramesh Chandrababu; Revathi P Shenoy

17

Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort

World Journal of Gastroenterology 27(7) (2021)

Kento Imajo; Louise Tetlow; Andrea Dennis; Elizabeth Shumbayawonda; Sofia Mouchti; Timothy J Kendall; Eve Fryer; Shogi Yamanaka; Yasushi Honda; Takaomi Kessoku; Yuji Ogawa; Masato Yoneda; Satoru Saito; Catherine Kelly; Matt D Kelly; Rajarshi Banerjee; Atsushi Nakajima

19

The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study

American Journal of Transplantation 20(8) (2020)

Katelynn Madill-Thomsen; Marwan Abouljoud; Chandra Bhati; Michał Ciszek; Magdalena Durlik; Sandy Feng; Bartosz Foroncewicz; Iman Francis; Michał Grąt; Krzysztof Jurczyk; Goran Klintmalm; Maciej Krasnodębski; Geoff McCaughan; Rosa Miquel; Aldo Montano-Loza; Dilip Moonka; Krzysztof Mucha; Marek Myślak; Leszek Pączek; Agnieszka Perkowska-Ptasińska; Grzegorz Piecha; Trevor Reichman; Alberto Sanchez-Fueyo; Olga Tronina; Marta Wawrzynowicz-Syczewska; Andrzej Więcek; Krzysztof Zieniewicz; Philip F. Halloran

20

Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH

Hepatology 78(4) (2023)

Jiahui Li; Xin Lu; Zheng Zhu; Kyle J. Kalutkiewicz; Taofic Mounajjed; Terry M. Therneau; Sudhakar K. Venkatesh; Yi Sui; Kevin J. Glaser; Safa Hoodeshenas; Armando Manduca; Vijay H. Shah; Richard L. Ehman; Alina M. Allen; Meng Yin

23

Artificial intelligence in the estimation of fat content in liver biopsies for liver transplantation: a systematic review

International Journal of Surgery (2026)

Danielle M. Wilmes; Evan J. Catron; Robert P. Passarelli; Plamen Mihaylov; Ping Li; Wenjun Zhang; Yucel Yankol; Richard S. Mangus; Marc L. Melcher; Burcin Ekser

24

Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis

Abdominal Radiology 44(2) (2019)

Jonathan C. Hooker; Gavin Hamilton; Charlie C. Park; Steven Liao; Tanya Wolfson; Soudabeh Fazeli Dehkordy; Cheng William Hong; Adrija Mamidipalli; Anthony Gamst; Rohit Loomba; Claude B. Sirlin

25

Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Gastroenterology 170(4) (2026)

Rohit Loomba; Virginia C. Clark; Mattias Mandorfer; Marc Miravitlles; Mark Brantly; Saul J. Karpen; Aleksander Krag; Paul Y. Kwo; Don C. Rockey; Mark W. Russo; Antonio J. Sanchez; Scott Santarella; Suzanne R. Sharpton; Charlie Strange; Jeffrey H. Teckman; Alice M. Turner; Hugo E. Vargas; Pavel Strnad

26

Nonalcoholic Fatty Liver Disease: Different Classifications Concordance and Relationship between Degrees of Morphological Features and Spectrum of the Disease

Analytical Cellular Pathology 2014 (2014)

Juliana Maya Monteiro; Geysa Maya Monteiro; Adriana Caroli-Bottino; Vera Lucia Pannain

27

Reliability of diagnosis from Mohs slides: interpersonal and intrapersonal agreement on basal cell carcinoma presence and histological subtype

British Journal of Dermatology 175(3) (2016)

C.B. van Lee; E.E.F. Ip Vai Ching; K. Nasserinejad; H.A.M. Neumann; M.G.W. Bol; P.K. Dikrama; N.W.J. Kelleners-Smeets; S. Koljenović; K. Munte; V. Noordhoek Hegt; H.C. de Vijlder; T. Nijsten; R.R. van den Bos

28

The evolving role of liver biopsy in chronic liver disease: a pathological and clinical perspective

Egyptian Liver Journal 16(1) (2026)

Fereshteh Sharbati; Reza Rezaei

29

Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI

The British Journal of Radiology (2018)

Guilherme Moura Cunha; Kevin J Glaser; Anke Bergman; Rodrigo P Luz; Eduardo H de Figueiredo; Flavia Paiva Proença Lobo Lopes

30

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

The Lancet Gastroenterology & Hepatology 6(3) (2021)

David Petroff; Valentin Blank; Philip N Newsome; Shalimar; Cosmin Sebastian Voican; Maja Thiele; Victor de Lédinghen; Stephan Baumeler; Wah Kheong Chan; Gabriel Perlemuter; Ana-Carolina Cardoso; Sandeep Aggarwal; Magali Sasso; Peter J Eddowes; Michael Allison; Emmanuel Tsochatzis; Quentin M Anstee; David Sheridan; Jeremy F Cobbold; Sylvie Naveau; Monica Lupsor-Platon; Sebastian Mueller; Aleksander Krag; Marie Irles-Depe; David Semela; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Cristiane A Villela-Nogueira; Harshit Garg; Olivier Chazouillères; Johannes Wiegand; Thomas Karlas

31

Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease

Diabetes/Metabolism Research and Reviews 42(2) (2026)

Fang Yang; Xueyue Sun; Kui Jiang; Mingxin Zhang; Chao Sun

33

Deep Parenchymal Steatosis Assessment and Quantification in Histopathology

IEEE Access 13 (2025)

Rishit Gupta; Amit Nagora; Phidakordor Sahshong; Parth Parekh; Apurba Chakraborty; Manish Bhatt

34

Automated hemangioma detection using Otsu based binarized Kaze features

Multimedia Tools and Applications 79(33-34) (2020)

Uğurhan Kutbay

35

Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection

American Journal of Surgical Pathology 41(3) (2017)

Won-Tak Choi; Kuang-Yu Jen; Dongliang Wang; Mehdi Tavakol; John P. Roberts; Ryan M. Gill

37

Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques

Therapeutic Advances in Gastroenterology 17 (2024)

David Hudson; Tamoor Afzaal; Hasan Bualbanat; Raaed AlRamdan; Nisha Howarth; Pavithra Parthasarathy; Alia AlDarwish; Emily Stephenson; Yousef Almahanna; Maytham Hussain; Luis Antonio Diaz; Juan Pablo Arab

38

Exposure–response modeling of liver fat imaging endpoints in non‐alcoholic fatty liver disease populations administered ervogastat alone and co‐administered with clesacostat

CPT: Pharmacometrics & Systems Pharmacology 14(2) (2025)

Jim H. Hughes; Neeta B. Amin; Jessica Wojciechowski; Manoli Vourvahis

39

Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease

Scientific Reports 9(1) (2019)

Nobuharu Tamaki; Mayu Higuchi; Masayuki Kurosaki; Sakura Kirino; Leona Osawa; Keiya Watakabe; Wan Wang; Mao Okada; Takao Shimizu; Kenta Takaura; Hitomi Takada; Shun Kaneko; Yutaka Yasui; Kaoru Tsuchiya; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Nobuyuki Enomoto; Namiki Izumi

40

Double Graph Attention Network for predicting non-alcoholic fatty liver disease in patients with type 2 diabetes

Artificial Intelligence in Medicine 174 (2026)

Tianbin Chen; Yongbin Zeng; Jinlin Wang; Xiao Sun; Sihao Liu; Ya Fu; Qiang Yi; Qishui Ou; Kai Yan; Zhiheng Zhou

42

Study of Methionine Choline Deficient Diet-Induced Steatosis in Mice Using Endogenous Fluorescence Spectroscopy

Molecules 24(17) (2019)

Alma Valor; Eduardo J. Arista Romeu; Galileo Escobedo; Adriana Campos-Espinosa; Ivette Irais Romero-Bello; Javier Moreno-González; Diego A. Fabila Bustos; Suren Stolik; Jose Manuel de la Rosa Vázquez; Carolina Guzmán

44

Limited use of FIB‐4 index in patients under 65 years of age with type 2 diabetes mellitus

Hepatology Research 55(4) (2025)

Mimi Kim; Eileen L. Yoon; Huiyul Park; Takanori Ito; Masatoshi Ishigami; Ae Jung Jo; Chul‐Min Lee; Bo‐Kyeong Kang; Hye‐Lin Kim; Taeang Arai; Masanori Atsukawa; Miwa Kawanaka; Hidenori Toyoda; Ming‐Lung Yu; Dae Won Jun; Mindie H. Nguyen

45

R2 relaxometry based MR imaging for estimation of liver iron content: A comparison between two methods

Abdominal Radiology 44(9) (2019)

Juan S. Calle-Toro; Christian A. Barrera; Dmitry Khrichenko; Hansel J. Otero; Suraj D. Serai

46

Deep learning quantification of percent steatosis in donor liver biopsy frozen sections

EBioMedicine 60 (2020)

Lulu Sun; Jon N. Marsh; Matthew K. Matlock; Ling Chen; Joseph P. Gaut; Elizabeth M. Brunt; S. Joshua Swamidass; Ta-Chiang Liu

47

A Scoping Review of the Photographic Assessment of Donor Liver Steatosis in Transplantation Using Artificial Intelligence

Clinical Transplantation 40(2) (2026)

Georgios Kourounis; Samuel J. Tingle; Ali Elmahmudi; Brian Thomson; Robin Nandi; Emily Thompson; Barney Stephenson; James Hunter; Hassan Ugail; Neil S. Sheerin; Colin Wilson

48

Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches

World Journal of Gastroenterology 32(2) (2026)

Pablo Guillermo Hernández-Almonacid; Ximena Marín-Quintero

49

Deep learning enables pathologist-like scoring of NASH models

Scientific Reports 9(1) (2019)

Fabian Heinemann; Gerald Birk; Birgit Stierstorfer

50

Quantitative MR biomarkers in identifying steatohepatitis and fibrosis associated with metabolic dysfunction associated liver disease—a single center cross-sectional study

Abdominal Radiology (2026)

Srinivas Meharwade; Sanchita Gupta; Ankur Goyal; Devasenathipathy Kandasamy; Shalimar; Shivanand Gamanagatti; Prasenjit Das; Amit Mehndiratta; Mani Kalaivani; Raju Sharma

51

Morphometric Quantification of Steatosis and Fibrosis in Metabolic Liver Disease Associated With Type 2 Diabetes

Clinical Gastroenterology and Hepatology 24(5) (2026)

Oliver Fourati; Pauline Manchon; Phillipe Garteiser; Laurent Castera; Marco Dioguardi Burgio; Bernard Van Beers; Pierre Bedossa; Miguel Albuquerque; Thierry Poynard; Cédric Laouenan; Dominique Valla; Valéri Paradis

52

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

Journal of Hepatology 73(6) (2020)

Beth A. Davison; Stephen A. Harrison; Gad Cotter; Naim Alkhouri; Arun Sanyal; Christopher Edwards; Jerry R. Colca; Julie Iwashita; Gary G. Koch; Howard C. Dittrich

53

Classification of the Stages of Nonalcoholic Steatohepatitis via Federated General Visual Representation Learning

International Journal of Imaging Systems and Technology 34(4) (2024)

Mehmet Nergiz

54

CONTEST: A generalization of ONEST to estimate sample size for predictive augmented intelligence method validation studies

Journal of Pathology Informatics 19 (2025)

Benjamin K. Olson; Joseph H. Rosenthal; Ryan D. Kappedal; Niels H. Olson

55

Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography

European Radiology 29(11) (2019)

Ziying Yin; Matthew C. Murphy; Jiahui Li; Kevin J. Glaser; Amy S. Mauer; Taofic Mounajjed; Terry M. Therneau; Heshan Liu; Harmeet Malhi; Armando Manduca; Richard L. Ehman; Meng Yin

56

État des lieux sur la physiopathologie, le diagnostic et les traitements de la stéato-hépatite non alcoolique (NASH)

Annales Pharmaceutiques Françaises 81(2) (2023)

G. Grzych; L. Bernard; R. Lestrelin; A. Tailleux; B. Staels

57

The Influence of Dietary Fat on Liver Fat Accumulation

Nutrients 6(11) (2014)

Charlotte Green; Leanne Hodson

58

Visual assessment of liver steatosis at retrieval predicts long term liver transplant outcomes in donation following circulatory death

HPB 27(5) (2025)

Ning X. Ho; Samuel J. Tingle; Georgios Kourounis; Balaji Mahendran; Rebecca Bramley; Emily R. Thompson; Aimen Amer; Rodrigo Figueiredo; Stuart McPherson; Steve White; Colin Wilson

59

Defining an NK Cell–enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study

Transplantation 109(8) (2025)

Katelynn S. Madill-Thomsen; Patrick T. Gauthier; Marwan Abouljoud; Chandra Bhati; David Bruno; Michał Ciszek; Magdalena Durlik; Sandy Feng; Bartosz Foroncewicz; Michał Grąt; Krzysztof Jurczyk; Josh Levitsky; Geoff McCaughan; Daniel Maluf; Aldo Montano-Loza; Dilip Moonka; Krzysztof Mucha; Marek Myślak; Agnieszka Perkowska-Ptasińska; Grzegorz Piecha; Trevor Reichman; Olga Tronina; Marta Wawrzynowicz-Syczewska; Samir Zeair; Philip F. Halloran

60

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

Hepatology 80(1) (2024)

Vlad Ratziu; Sven Francque; Cynthia A. Behling; Vanja Cejvanovic; Helena Cortez-Pinto; Janani S. Iyer; Niels Krarup; Quang Le; Anne-Sophie Sejling; Dina Tiniakos; Stephen A. Harrison

62

Histological assessment based on liver biopsy: the value and challenges in NASH drug development

Acta Pharmacologica Sinica 43(5) (2022)

Xiao-fei Tong; Qian-yi Wang; Xin-yan Zhao; Ya-meng Sun; Xiao-ning Wu; Li-ling Yang; Zheng-zhao Lu; Xiao-juan Ou; Ji-dong Jia; Hong You

63

A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies

Modern Pathology 34(4) (2021)

Joshua J. Levy; Nasim Azizgolshani; Michael J. Andersen; Arief Suriawinata; Xiaoying Liu; Mikhail Lisovsky; Bing Ren; Carly A. Bobak; Brock C. Christensen; Louis J. Vaickus